soluble cr1 Search Results


soluble cr1 (scr1) brl55730  (Glaxo Smith)
90
Glaxo Smith soluble cr1 (scr1) brl55730
Binding of <t>sCR1</t> to nonactivated and TRAP-activated platelets exposed to native C3. The background level of sCR1 binding to platelets without the presence of C3 has been subtracted from the levels obtained in the presence of C3 for each individual experiment. The data are shown as means ± SEM (n = 7; *p < 0.05).
Soluble Cr1 (Scr1) Brl55730, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/soluble cr1 (scr1) brl55730/product/Glaxo Smith
Average 90 stars, based on 1 article reviews
soluble cr1 (scr1) brl55730 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
soluble cr1 (scr1)  (Cell Sciences Inc)
90
Cell Sciences Inc soluble cr1 (scr1)
Binding of <t>sCR1</t> to nonactivated and TRAP-activated platelets exposed to native C3. The background level of sCR1 binding to platelets without the presence of C3 has been subtracted from the levels obtained in the presence of C3 for each individual experiment. The data are shown as means ± SEM (n = 7; *p < 0.05).
Soluble Cr1 (Scr1), supplied by Cell Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/soluble cr1 (scr1)/product/Cell Sciences Inc
Average 90 stars, based on 1 article reviews
soluble cr1 (scr1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
recombinant soluble cr1  (AVANT Immunotherapeutics Inc)
90
AVANT Immunotherapeutics Inc recombinant soluble cr1
Binding of <t>sCR1</t> to nonactivated and TRAP-activated platelets exposed to native C3. The background level of sCR1 binding to platelets without the presence of C3 has been subtracted from the levels obtained in the presence of C3 for each individual experiment. The data are shown as means ± SEM (n = 7; *p < 0.05).
Recombinant Soluble Cr1, supplied by AVANT Immunotherapeutics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant soluble cr1/product/AVANT Immunotherapeutics Inc
Average 90 stars, based on 1 article reviews
recombinant soluble cr1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
soluble cr1  (AVANT Immunotherapeutics Inc)
90
AVANT Immunotherapeutics Inc soluble cr1
Binding of <t>sCR1</t> to nonactivated and TRAP-activated platelets exposed to native C3. The background level of sCR1 binding to platelets without the presence of C3 has been subtracted from the levels obtained in the presence of C3 for each individual experiment. The data are shown as means ± SEM (n = 7; *p < 0.05).
Soluble Cr1, supplied by AVANT Immunotherapeutics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/soluble cr1/product/AVANT Immunotherapeutics Inc
Average 90 stars, based on 1 article reviews
soluble cr1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
truncated soluble variant of cr1 lacking the lhr-d domain (csl040; csl ltd., melbourne, australia)  (CSL Limited)
90
CSL Limited truncated soluble variant of cr1 lacking the lhr-d domain (csl040; csl ltd., melbourne, australia)
Examples of complement inhibitor production yields in eukaryotic hosts.
Truncated Soluble Variant Of Cr1 Lacking The Lhr D Domain (Csl040; Csl Ltd., Melbourne, Australia), supplied by CSL Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/truncated soluble variant of cr1 lacking the lhr-d domain (csl040; csl ltd., melbourne, australia)/product/CSL Limited
Average 90 stars, based on 1 article reviews
truncated soluble variant of cr1 lacking the lhr-d domain (csl040; csl ltd., melbourne, australia) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
soluble cr1 (scrs 1–10 of cd35)  (Alexion Phrama)
90
Alexion Phrama soluble cr1 (scrs 1–10 of cd35)
Examples of complement inhibitor production yields in eukaryotic hosts.
Soluble Cr1 (Scrs 1–10 Of Cd35), supplied by Alexion Phrama, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/soluble cr1 (scrs 1–10 of cd35)/product/Alexion Phrama
Average 90 stars, based on 1 article reviews
soluble cr1 (scrs 1–10 of cd35) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Binding of sCR1 to nonactivated and TRAP-activated platelets exposed to native C3. The background level of sCR1 binding to platelets without the presence of C3 has been subtracted from the levels obtained in the presence of C3 for each individual experiment. The data are shown as means ± SEM (n = 7; *p < 0.05).

Journal:

Article Title: Complement Component C3 Binds to Activated Normal Platelets without Preceding Proteolytic Activation and Promotes Binding to Complement Receptor 1

doi: 10.4049/jimmunol.0902810

Figure Lengend Snippet: Binding of sCR1 to nonactivated and TRAP-activated platelets exposed to native C3. The background level of sCR1 binding to platelets without the presence of C3 has been subtracted from the levels obtained in the presence of C3 for each individual experiment. The data are shown as means ± SEM (n = 7; *p < 0.05).

Article Snippet: Soluble CR1 (sCR1) BRL55730 was a kind gift from Dr. Henry Marsh (GlaxoSmithKline, Research Triangle Park, NC).

Techniques: Binding Assay

Examples of complement inhibitor production yields in eukaryotic hosts.

Journal: Biomedicines

Article Title: The Production of Complement Inhibitor Proteins in Mammalian Cell Lines—Light at the End of the Tunnel?

doi: 10.3390/biomedicines12030646

Figure Lengend Snippet: Examples of complement inhibitor production yields in eukaryotic hosts.

Article Snippet: A truncated soluble variant of CR1 lacking the LHR-D domain (CSL040; CSL Ltd., Melbourne, Australia) has recently been introduced [ ] and characterized by exhibiting greater in vitro potency and an extended in vivo half-life compared with full-length CR1.

Techniques: